Anastasiou-Nana M, Levis G M, Moulopoulos S
Int J Clin Pharmacol Ther Toxicol. 1982 Nov;20(11):524-9.
Pharmacokinetic studies were conducted in four subjects who received 150 mg amiodarone i.v., in nine subjects who received 200 or 400 mg amiodarone p.o., and in four subjects who received the drug by both routes of administration. Amiodarone concentrations were determined by high pressure liquid chromatography. Aminodarone levels after i.v. administration, with one exception, declined biphasically according to a two-compartment model. The decline appeared to be monophasic after p.o. administration with one exception. Plasma levels after p.o. administration varied considerably between subjects. The biologic half-life after p.o. administration (mean 17.1 h +/- S.D.) was higher than that calculated for the second phase after i.v. administration (mean 4.3 h +/- 0.98 S.D.). Total clearance rate during the second phase was within the range 125-288 ml/min after i.v. and 114-473 ml/min after p.o. administration. The apparent volume of distribution in the central compartment after i.v. administration was found to be about 17.0 l and that calculated for the second elimination phase, 77 l, possibly indicating a concentration of the drug in the tissues. The systemic availability of amiodarone varied from 23 to 50% as determined on the basis of of the ratios of areas under p.o. and i.v. serum concentration curves for four subjects.
对4名静脉注射150毫克胺碘酮的受试者、9名口服200或400毫克胺碘酮的受试者以及4名通过两种给药途径接受该药物的受试者进行了药代动力学研究。胺碘酮浓度通过高压液相色谱法测定。静脉给药后,除一例例外,胺碘酮水平根据二室模型呈双相下降。口服给药后,除一例例外,下降似乎呈单相。口服给药后受试者之间的血浆水平差异很大。口服给药后的生物半衰期(平均17.1小时±标准差)高于静脉给药后第二阶段计算的半衰期(平均4.3小时±0.98标准差)。静脉给药后第二阶段的总清除率在125 - 288毫升/分钟范围内,口服给药后为114 - 473毫升/分钟。静脉给药后中央室的表观分布容积约为17.0升,第二消除阶段计算的表观分布容积为77升,这可能表明药物在组织中的浓度。根据4名受试者口服和静脉血清浓度曲线下面积的比值确定,胺碘酮的全身可用性在23%至50%之间。